DID YOU KNOW? DTIC has over 3.5 million final reports on DoD funded research, development, test, and evaluation activities available to our registered users. Click
HERE to register or log in.
Accession Number:
AD1039576
Title:
Targeting Signaling to YAP for the Therapy of NF2
Descriptive Note:
Technical Report,30 Sep 2014,29 Sep 2016
Corporate Author:
Memorial Sloan Kettering Cancer Center New York United States
Report Date:
2016-12-01
Pagination or Media Count:
11.0
Abstract:
The goals of this project are to utilize our new knowledge of the mechanism by which loss of Merlin induces tumorigenesis to identify small molecule compounds that block YAPTEAD-dependent transcription by acting at any step of our newly identified pathway, and to test the preclinical efficacy of lead compounds in xenograft models of NF2. During this grant, we have generated NF2 mutant cell lines expressing two different types of YAP reporters and tested their suitability for high throughput screening.
Distribution Statement:
APPROVED FOR PUBLIC RELEASE